Starpharma – drug delivery deal with Astra Zeneca
A long standing collaboration between reached a significant commercialisation milestone when Starpharma signed a major licencing deal with the global pharmaceutical company . MIPS scientists have worked with Starpharma for over 10 years and are co-inventors on some of Starpharma's DEP® drug delivery patents. This platform improves delivery of anti-cancer agents to tumour sites, and reduces toxicities often seen during chemotherapy.
This is another example of the power of deep and enduring academic-industrial collaborations within the Australian biotechnology ecosystem – focused on translation of science in areas of unmet medical need and highlights Monash's commitment to nanoscience and progress towards the development of next generation nanomedicines.
See related news story.